Supporting evidence includes increased exogenous lipid utilization, where breast cancer cells induce adipocytes to release FFA via activation of lipolysis (increased expression of ATGL and HSL) and inhibition of adipogenesis (through decreased expression of peroxisome proliferator-activated receptor-γ) (6, 8). This evidence concerns the gene PNPLA2 and breast cancer.